See original here:
Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing
Author Archives: Danzig
GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment
Clene Announces Plans to Submit Briefing Book to the U.S. Food and Drug Administration in Connection with Granted Type C Interaction to Obtain FDA…
Eloxx Pharmaceuticals Provides Pipeline and Financing Updates
Continue reading here:
Eloxx Pharmaceuticals Provides Pipeline and Financing Updates
Virbac: Termination of the liquidity contract
Here is the original post:
Virbac: Termination of the liquidity contract
Oxurion provides clarification on the agenda of the extraordinary general shareholders’ meeting to be held on 24 July 2024
Revolution Medicines Announces Publication Demonstrating Robust Anti-Tumor Activity of RAS(ON) Inhibitors in Preclinical Models of Refractory…
Tevogen Bio Issues Letter to Stockholders Highlighting Recent Achievements, Growth Plans, and Consideration of a Potential Share Buyback
Nurix Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
See the original post here:
Nurix Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
Spectral Medical Inc. Announces Change to Auditor
Oncternal Therapeutics to Present in JonesTrading Healthcare Summit
Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024
Go here to read the rest:
Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024
Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors
Immutep Reports Positive Results in First Line Head and Neck Squamous Cell Carcinoma Patients with Negative PD-L1 Expression
Annexon to Present Additional Phase 2 Data Showing Preservation of Visual Function and Structure by ANX007 in Geographic Atrophy at the 42nd ASRS…
Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)
Here is the original post:
Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)